0001213900-23-080478.txt : 20230928 0001213900-23-080478.hdr.sgml : 20230928 20230928160940 ACCESSION NUMBER: 0001213900-23-080478 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230927 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spectral AI, Inc. CENTRAL INDEX KEY: 0001833498 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40058 FILM NUMBER: 231289702 BUSINESS ADDRESS: STREET 1: 2515 MCKINNEY AVE #1000 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (212) 492-3000 MAIL ADDRESS: STREET 1: 2515 MCKINNEY AVE #1000 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: Rosecliff Acquisition Corp I DATE OF NAME CHANGE: 20201123 8-K 1 ea185884-8k_spectral.htm CURRENT REPORT
0001833498 false 0001833498 2023-09-27 2023-09-27 0001833498 MDAI:CommonStockParValue0.0001PerShareMember 2023-09-27 2023-09-27 0001833498 MDAI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2023-09-27 2023-09-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 27, 2023

 

SPECTRAL AI, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40058   85-3987148
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

2515 McKinney Avenue, Suite 1000
Dallas, Texas

   75201
(Address of principal executive offices)   (Zip Code)

 

(972) 499-4934

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   MDAI   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share   MDAIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On September 27, 2023, Spectral AI, Inc. (the “Company”), entered into a contract (the “BARDA Contract”) with the Biomedical Advanced Research and Development Authority (“BARDA”). BARDA is a division of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. Under the BARDA Contract, the Company will receive an award to support the advanced development of the DeepView® System, the Company’s AI-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a medical countermeasure for use in burn mass casualty incidents.

 

The BARDA Contract could result in payments to the Company of up to approximately $149 million. The BARDA Contract consists of an initial base period and option periods that BARDA may exercise, subject to the Company achieving specified milestones and deliverables. Together with the Company’s previously awarded BARDA contracts, the BARDA Contract brings the total support from BARDA to nearly $251 million.

 

The BARDA Contract contains terms and conditions that are customary for government contracts of this nature, including provisions giving the government the right to terminate the contract at any time for its convenience.

 

The foregoing is a brief description of the material terms of the BARDA Contract and does not purport to be a complete description of the rights and obligations of the parties thereunder. The foregoing description is qualified in its entirety by reference to the BARDA Contract, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ending September 30, 2023.

 

Item 7.01. Regulation FD Disclosure.

 

On September 28, 2023, the Company issued a press release announcing its entry into the BARDA Contract, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. 

 

The information in this Item 7.01 to this Current Report on Form 8-K, and in Exhibit 99.1 furnished herewith, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
99.1   Press Release issued by Spectral AI, Inc. on September 28, 2023
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 28, 2023

 

  SPECTRAL AI, INC.
   
  By: /s/ Wensheng Fan
  Name:  Wensheng Fan
  Title: Chief Executive Officer

 

 

2 

 

 

 EX-99.1 2 ea185884ex99-1_spectral.htm PRESS RELEASE ISSUED BY SPECTRAL AI, INC. ON SEPTEMBER 28, 2023

Exhibit 99.1 

 

Spectral MD Awarded BARDA Project BioShield Contract Valued at $149 Million for

AI-Driven DeepView® Burn Wound Imaging Technology

 

DALLAS, Sept. 28, 2023 – Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has been awarded a new contract valued at up to $149 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. The contract is for the advanced development of the DeepView® System, the Company’s AI-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a medical countermeasure for use in burn mass casualty incidents (BMCI).

 

This multi-year contract includes an initial award of nearly $55 million to support the clinical validation and FDA clearance of DeepView® for commercial marketing and distribution purposes, a major milestone that enables the technology to become a key component of the U.S. government’s BMCI preparedness efforts. The initial award places up to 30 DeepView® devices at various burn centers and emergency rooms to support the clinical validation study and will transition to being used in routine care upon FDA clearance. The contract also includes options with an additional total value of approximately $95 million and can be exercised for additional product development, procurement, and deployment of DeepView® at U.S. emergency departments, trauma centers and burn centers in a phased approach. These deployments will enable SMD to conduct health economic and outcome research to support broader clinical adoption of the DeepView® System.

 

Previously in 2013 and 2019, SMD was awarded BARDA contracts totaling $123 million, of which $101 million has been committed to date. Together with this new contract, it brings the total potential support from BARDA to nearly $251 million. This new contract represents the largest contract ever awarded to SMD.

 

“We appreciate that our DeepView® platform has been selected to address a critical need in preparing our country for possible BMCI events,” said Wensheng Fan, the Company’s CEO. “This is a significant contract award that enables us to accelerate the late-stage clinical development and commercialization of our DeepView® System. We are most grateful to BARDA for enabling us to help physicians and their burn patients who will benefit from the use of DeepView®. For the first time, there will be an accurate and objective solution in burn wound healing assessment to guide treatment. Spectral MD is committed to the development of impactful medical technologies, and we will aim to bring DeepView® to market as quickly as possible.”

 

Jeffrey Carter, M.D., the Company’s Chief Medical Consultant, added, “The current standard of care for burn wound assessment that is crucial in determining next-step treatment relies largely on the clinical judgement of physicians. However, diagnostic accuracy can be as low as 50%. This unmet clinical need is dramatically magnified in the event of a BMCI, where the ability to triage burn patients rapidly and properly would be crucial in allocating valuable resources and managing the surgical burden. The DeepView® technology represents a new paradigm in the assessment of burn wounds and can provide meaningful clinical guidance to physicians in their diagnosis and treatment recommendations.”

 

This work supports BARDA’s mission to identify medical countermeasures which help counter the effects of a BMCI and address the current limitations within the United States’ burn care infrastructure. According to the American Burn Association, 1.1 million Americans suffer from burn injuries each year, with 500,000 presenting to emergency departments, and 40,000 requiring hospitalization. In contrast to this demand, only two percent of U.S. hospitals have burn centers, and there are only about 250 burn surgeons in the United States.

 

To bridge this gap in care, the Company’s DeepView® System, which received Breakthrough Device Designation from the FDA in 2017 for its burn indication, integrates proprietary imaging technology and AI-enabled algorithms to see deep below the surface of the skin to distinguish between healthy and damaged tissue. By seeing what the human eye cannot, DeepView® delivers a binary wound healing prediction to assist physicians in determining whether a burn will heal on its own or if surgery is required. Studies with DeepView® have demonstrated a burn diagnostic accuracy rate of 92% on Day 1, well above the estimated >50% accuracy of non-specialists and even the estimated 70% accuracy of burn specialist assessments.

 

 

 

 

This project is being supported in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; BARDA, under contract number 75A50123C00049. The findings and conclusions have not been formally disseminated by the Department of Health and Human Services and should not be construed to represent any agency determination or policy.

 

About Spectral MD

 

Spectral MD, Inc., is a subsidiary of Spectral AI, Inc., a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.

 

Forward Looking Statements

 

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

 

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

 

Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

 

Contacts:  
   
Investors:  
   
The Equity Group  
Devin Sullivan Conor Rodriguez
Managing Director Analyst
dsullivan@equityny.com crodriguez@equityny.com
   
Media:  
   
Russo Partners  
David Schull or Guillermo Ruiz, M.D., Ph.D. Guillermo Ruiz, M.D., Ph.D.
Russo Partners Russo Partners
(858) 717-2310 (858) 717-2310
david.schull@russopartnersllc.com Guillermo.ruiz@russopartnersllc.com

 

 

 

 

 

 EX-101.SCH 3 mdai-20230927.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 mdai-20230927_def.xml XBRL DEFINITION FILE EX-101.LAB 5 mdai-20230927_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.0001 per share Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 mdai-20230927_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 27, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 27, 2023
Entity File Number 001-40058
Entity Registrant Name SPECTRAL AI, INC.
Entity Central Index Key 0001833498
Entity Tax Identification Number 85-3987148
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2515 McKinney Avenue
Entity Address, Address Line Two Suite 1000
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75201
City Area Code 972
Local Phone Number 499-4934
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol MDAI
Security Exchange Name NASDAQ
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share  
Title of 12(b) Security Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share
Trading Symbol MDAIW
Security Exchange Name NASDAQ
XML 8 ea185884-8k_spectral_htm.xml IDEA: XBRL DOCUMENT 0001833498 2023-09-27 2023-09-27 0001833498 MDAI:CommonStockParValue0.0001PerShareMember 2023-09-27 2023-09-27 0001833498 MDAI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2023-09-27 2023-09-27 iso4217:USD shares iso4217:USD shares 0001833498 false 8-K 2023-09-27 SPECTRAL AI, INC. DE 001-40058 85-3987148 2515 McKinney Avenue Suite 1000 Dallas TX 75201 972 499-4934 false false false false Common Stock, par value $0.0001 per share MDAI NASDAQ Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share MDAIW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" M / " 041 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 M" Q@3Q7)!Z;HJT #X 0 &@ @ %E$@ >&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " Q@3Q799!YDAD! #/ P M$P @ %*$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" "4% ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 3 24 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://spectralmd.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea185884-8k_spectral.htm mdai-20230927.xsd mdai-20230927_def.xml mdai-20230927_lab.xml mdai-20230927_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea185884-8k_spectral.htm": { "nsprefix": "MDAI", "nsuri": "http://spectralmd.com/20230927", "dts": { "inline": { "local": [ "ea185884-8k_spectral.htm" ] }, "schema": { "local": [ "mdai-20230927.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "mdai-20230927_def.xml" ] }, "labelLink": { "local": [ "mdai-20230927_lab.xml" ] }, "presentationLink": { "local": [ "mdai-20230927_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://spectralmd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea185884-8k_spectral.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea185884-8k_spectral.htm", "first": true, "unique": true } } }, "tag": { "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "MDAI_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://spectralmd.com/20230927", "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $11.50 per share" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://spectralmd.com/role/Cover" ], "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "MDAI_CommonStockParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://spectralmd.com/20230927", "localname": "CommonStockParValue0.0001PerShareMember", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.0001 per share" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://spectralmd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001213900-23-080478-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-080478-xbrl.zip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end